We have previously shown that 6-ECDCA, also known as obeticholic acid, a dual FXR and GPBAR1 ligand, attenuates liver steatosis that develop in ApoE−/− mice and Zucker rats16, 17. This evidence concerns the gene NR1H4 and Hepatic steatosis.